Search | Page 8 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Decision points in the treatment of transfusional iron overload in patients with myelodysplastic syndromes: why, when, and how to chelate

    ... INTRODUCTION: Patients with myelodysplastic syndromes (MDS) differ from those with other transfusion-dependent ...

    Research Article last updated 01/26/2017 - 10:17am.

  2. TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes

    ... therapy in patients with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) are unclear. Methods We enrolled 84 adult patients with AML ...

    Research Article last updated 01/26/2017 - 10:07am.

  3. Outcomes after Umbilical Cord Blood Transplantation for Myelodysplastic Syndromes

    ... solely to describing the outcomes of adult patients with myelodysplastic syndrome (MDS) who have undergone UCBT. From 2004 to 2013, 176 ... Bone Marrow Diseases:  myelodysplastic syndromes (MDS) ...

    Research Article last updated 03/22/2017 - 9:24am.

  4. Mutated ASXL1 and number of somatic mutations as possible indicators of progression to chronic myelomonocytic leukemia of myelodysplastic syndromes with single or multilineage dysplasia

    ... Bone Marrow Diseases:  myelodysplastic syndromes (MDS) ...

    Research Article last updated 06/22/2017 - 11:41am.

  5. Poly (ADP-ribose) polymerase 1 mRNA levels strongly correlate with the prognosis of myelodysplastic syndromes.

    ... PCR in the bone marrow of 74 patients with myelodysplastic syndrome (MDS) and correlated them to their demographic, ... Bone Marrow Diseases:  myelodysplastic syndromes (MDS) ...

    Research Article last updated 03/09/2017 - 1:47pm.

  6. Molecular features of early onset adult myelodysplastic syndrome

    ... Myelodysplastic syndromes are typically diseases of older adults. Early onset patients may ...

    Research Article last updated 03/22/2017 - 10:52am.

  7. Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat in Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: North American Intergroup Study SWOG S1117

    ... is standard, first-line therapy in higher-risk myelodysplastic syndromes (MDS). Whether azacitidine-based combinations with ... Bone Marrow Diseases:  myelodysplastic syndromes (MDS) ...

    Research Article last updated 05/22/2017 - 10:52am.

  8. Vincent Rusak

    ... Links Myelodysplastic Syndromes ...

    "Like You" Patient Story last updated 07/05/2017 - 11:14am.

  9. Myelodysplastic Syndromes Treatment (PDQ®): Patient Version

    ... summary has current information about the treatment of myelodysplastic syndromes . It is meant to inform and help patients, families, and ...

    Research Article last updated 12/02/2015 - 9:07am.

  10. Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndrome

    ... thalassemia, whereas its effect is unclear in those with myelodysplastic syndromes (MDS). In patients with sickle cell anemia (SCA), iron ...

    Research Article last updated 03/22/2017 - 10:46am.